Full Breakdown
Gaps in Apple Watch's High Blood Pressure Alerts Raise Concerns
2/11/2026, 2:32:57 AM
Overview of the Apple Watch Feature
The Apple Watch's new hypertension notification feature, approved by the U.S. Food and Drug Administration (FDA) in September 2025, aims to passively track blood flow and alert users to potential high blood pressure. However, a recent study published in the *Journal of the American Medical Association* highlights significant limitations in this feature, particularly for older adults and certain demographic groups.
Findings on Alert Effectiveness
Research led by Adam Bress from the University of Utah indicates that while the feature could help identify undiagnosed hypertension, it may also lead to a false sense of security. The study found that approximately 59% of individuals with undiagnosed hypertension would not receive an alert, while only 8% of those without hypertension would receive a false alert. For adults aged 60 and older, receiving an alert increases the likelihood of having high blood pressure from 45% to 81%. Conversely, not receiving an alert only reduces their likelihood to 34%, indicating that the absence of an alert is less reassuring for seniors.
Demographic Disparities
The study also revealed disparities among different demographic groups. For Black adults, receiving an alert raises the probability of high blood pressure from 36% to 75%, while not receiving an alert lowers it to 26%. In Hispanic adults, the alert increases the probability from 24% to 63%, with the absence of an alert reducing it to 17%. These findings underscore the need for traditional blood pressure screenings, as the smartwatch alerts should not replace standard medical evaluations.
Official Statements & Responses
Apple has clarified that the hypertension notification feature is not intended to diagnose or treat hypertension but is designed to prompt users to seek clinical evaluation if hypertension is suspected. The company emphasizes that not all individuals with high blood pressure will receive notifications, and the device cannot detect heart attacks. Experts, including those from Harvard's School of Public Health, caution against relying solely on the smartwatch for health alerts, warning that it may lead to deferred care and delayed diagnosis.
Criticism & Opposition
Critics argue that the Apple Watch's feature could discourage individuals from seeking necessary medical evaluations. The research team noted that the potential for misclassification could result in missed opportunities for early detection and treatment of hypertension. Professor Bryan Williams from the British Heart Foundation highlighted the importance of regular blood pressure checks, stating that untreated high blood pressure contributes to preventable heart attacks and strokes.
What's Next
Further studies are planned to investigate the accuracy of the Apple Watch's hypertension alerts and their real-world implications. Researchers stress the importance of using traditional cuff-based measurements to confirm any alerts received from the smartwatch.
Verbatim Quotes
- “High blood pressure is what we call a silent killer,” — Adam Bress, Professor of Population Health Sciences, University of Utah
- “Given that screening tests are expected to be good at ruling out a disease, the absence of a notification could lead to false reassurance, deferred care, and delayed diagnosis.” — Editorial from Harvard School of Public Health experts
- “Smart tech like this can be useful for people who want to keep a closer eye on various aspects of their health.” — Professor Bryan Williams, British Heart Foundation
